NervGen Pharma Corp. Common stock
public_traded
NervGen Pharma Corp. Common stock is publicly traded on NASDAQ under ticker NGEN.
NervGen Pharma Corp. is a clinical-stage biotechnology company developing therapies aimed at treating nerve damage and neurodegenerative conditions by targeting mechanisms that inhibit nervous system repair.